Wu-Pong, S., 1994, Pharmaceutical Technology, Oct., p. 102, 104, 106, 108, 110-112, 114.* |
Heidenreich et al., Molecular Medicine Today, vol. 1(3), p. 128-133, 1995.* |
Cameron, British Journal of Theatre Nursing (Aug. 1997) 7(5):5-7. |
Freelander, Hosp Med (Jun. 1998) 59(6):484-7. |
Jones et al., Nurs Stand (Jun. 17-23, 1998) 12(39):47-52. |
Spotnitz et al., Surg Clin North Am (Jun. 1997) 77(3):651-69. |
Staley et al., Adv Wound Care (Mar.-Apr. 1997) 10(2):39-44. |
Archer et al., 1994, Antimicrob. Agents Chemother. 38:2231-2237. |
Bennett, 1993, Antisense Res. Devel. 3:235-241. |
Cohen, 1989, Oligodeoxynucleotides; Antisense Inhibitors of Gene Expression, Boca Raton, FL, CRC Press. |
Crooke, 1997, in Antisense Nucleic Acid and Antisense RNA: Novel Pharmacological and Therapeutic Agents, B. Weiss ed., CRC Press Boca Raton, FL., p. 17. |
Goth, 1974, Medical Pharmacology: Principles and Concepts, The C.V. Mosby Company, Saint Louis, MO. |
Hoke et al., 1991, Nucl. Acids Res. 19:5743. |
Hughes et al., 1995, Pharmaceutical Research 12:817. |
Krieg et al., 1995, Nature 374:546-549. |
Kristinsson, 1995, Microb. Drug Resistance 1(2):121. |
Woodford et al., 1995, J. Antimicrob. Chemother. 35:179-184. |
Yamamoto et al., 1994, Antisense Res. Devel. 4:119-122. |
Zabransky et al., 1995, J. Clin. Microbiol. 33(4):791-793. |